血液透析通路建立后通路相关手部功能障碍
该纵向研究纳入39例接受血液透析通路手术的CKD或ESKD患者,术前和术后6周进行手部功能评估及肌肉活检。术后6周握力下降13.5±19.4%(P=0.0001),指压下降30.6±38.0 mm Hg(P=0.0008),患者报告的肢体残疾评分恶化(P=0.0213),肌纤维横截面积减少约12%(P=0.0340)。出现通路相关手部功能障碍(ARHD)的患者6个月无辅助成熟失败发生率约高20%(P=0.0046)。
要点
- 透析通路术后6周握力和指压显著下降,患者报告肢体残疾加重。
- 肌纤维横截面积减少约12%,且与握力下降显著相关。
- ARHD患者6个月无辅助成熟失败发生率约高20%。
核心结论
- CKD或ESKD患者血液透析通路手术后发生ARHD,与肌肉萎缩、转录组改变及通路成熟失败率增高相关。
研究设计与样本
- 纵向研究,纳入39例接受血液透析通路手术的CKD或ESKD患者,术前和术后6周评估手部功能并分析肱桡肌活检,随访6个月评估通路成熟失败。
主要发现
- 术后6周握力下降13.5±19.4%(P=0.0001),指压下降30.6±38.0 mm Hg(P=0.0008),患者报告肢体残疾评分恶化(P=0.0213)。
- 肌纤维横截面积减少约12%(P=0.0340),与握力显著相关(P=0.0488)。
- 线粒体含量增加(P=0.0683)且与指压负相关(P=0.0321),线粒体呼吸和抗氧化能力无变化。
- RNA测序显示调控肌纤维发育的基因发生改变。
- ARHD患者6个月无辅助成熟失败发生率约高20%(P=0.0046)。
临床怎么用
- 透析通路术后应早期识别ARHD,并考虑针对性干预以预防ARHD和改善通路手术结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Patients with chronic kidney disease (CKD) or end-stage kidney disease (ESKD) frequently experience access-related hand dysfunction (ARHD) following hemodialysis access placement, negatively impacting clinical outcomes and quality of life. Despite its prevalence, the mechanisms underlying ARHD remain poorly understood, and its impact on subsequent access maturation failure has not been well-characterized. METHODS: We conducted a longitudinal study of 39 patients with CKD or ESKD undergoing hemodialysis access surgery. Functional assessments, including grip strength, finger pressure, patient-reported hand or arm disability, dexterity, and sensory testing were performed preoperatively and 6 weeks postoperatively. Brachioradialis muscle biopsies were analyzed for morphological changes, mitochondrial function, and transcriptomic profiles. Dialysis access maturation failure was evaluated at 6-month follow-up. RESULTS: Six weeks after surgery, grip strength declined by 13.5 ± 19.4% (P = 0.0001), finger pressure decreased by 30.6 ± 38.0 mm Hg (P = 0.0008), and patient-reported limb disability scores worsened (P = 0.0213). Dexterity and sensation showed no changes. Histological analysis revealed an approximately 12% reduction in myofiber cross-sectional area (P = 0.0340), which is significantly correlated with grip strength (P = 0.0488). Mitochondrial content increased (P = 0.0683) and was inversely correlated with finger pressure (P = 0.0321), whereas mitochondrial respiration and antioxidant capacity remained unchanged. RNA sequencing revealed alterations in the genes regulating myofiber development. Notably, patients with ARHD had an approximately 20% higher incidence of unassisted maturation failure at 6 months (P = 0.0046). CONCLUSION: In patients with CKD or ESKD, hemodialysis access surgery results in ARHD, which is associated with muscle atrophy, altered transcriptomic profiles, and higher incidence of access maturation failure. These findings underscore the need for early identification and targeted interventions to prevent ARHD and improve dialysis-access surgery outcomes.
引用
- Kim K, Thome T, Stone L, et al. Access-Related Hand Dysfunction After Hemodialysis Access Placement. Kidney Int Rep. 2026. PMID: 41704900. doi:10.1016/j.ekir.2025.103765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。